Top

Reactions Weekly

Published in:

01-12-2017 | Case report

Alemtuzumab

Cervical dysplasia: 2 case reports

Published in: Reactions Weekly | Issue 1/2017

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Nesbitt C, et al. Incidence of cervical dysplasia in females receiving alemtuzumab: An Australian single centre observational study. Multiple Sclerosis Journal 23 (Suppl. 1): 908 abstr. EP1724, No. 3, 24 Oct 2017. Available from: URL: http://doi.org/10.1177/1352458517731285 [abstract] - Australia

Title: Alemtuzumab
Cervical dysplasia: 2 case reports
Publication date: 01-12-2017
Publisher: Springer International Publishing
Published in: Reactions Weekly / Issue 1/2017
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-017-39304-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Alemtuzumab

Cervical dysplasia: 2 case reports

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2017

Methylthioninium chloride and venlafaxine interaction/remifentanil

Bupivacaine/clonidine/hydromorphone

Metformin toxicity

Antineoplastics

PCSK9 inhibitors: drug safety prediction using gene variants

Interferon-α-2b/ isotretinoin